August Newsletter: Looking Ahead to a New Season of Growth for Innitius linkedin.com/pulse/august-n…
Innitius
@_INNITIUS
Actionable Diagnostics for Women's Health
766 Following 267 Followers 668 Posts
Latest posts 5
Welcome Dr. Benjamin Sommerkorn, Our Director of Quality & Regulatory Affairs! 🎉
Ben will define & execute our regulatory strategy, oversee audits and risk management, to ensure that our work stays aligned with evolving regulatory frameworks. Welcome to the Innitius family! 👏🏼
Ben will define & execute our regulatory strategy, oversee audits and risk management, to ensure that our work stays aligned with evolving regulatory frameworks. Welcome to the Innitius family! 👏🏼
🌍 New series: Why I Work in Maternal Health
Meet Irene, our Regulatory Affairs Manager:
“Maternal health matters to everyone. At Innitius, I want to improve research for pregnant women so care is based on real evidence. When we care for mothers, we care for the future.” 🤍
Meet Irene, our Regulatory Affairs Manager:
“Maternal health matters to everyone. At Innitius, I want to improve research for pregnant women so care is based on real evidence. When we care for mothers, we care for the future.” 🤍
At Innitius, we believe that healthcare should never be a guessing game.
Our technology, CerviSense, gives clinicians real-time insights into cervical consistency, helping them make faster, more accurate decisions during some of the most critical moments in maternal care.
Our technology, CerviSense, gives clinicians real-time insights into cervical consistency, helping them make faster, more accurate decisions during some of the most critical moments in maternal care.
📢 Exciting News!! Our FB-CT2 Safety Pilot Study Has Been Completed Ahead of Schedule - CerviSense is Ready for Pivotal Phase! Read more about it in our latest newsletter: linkedin.com/pulse/july-new…
